GKT136901 hydrochloride - CAS# 1254507-01-1


Catalog No. Size PriceQuantity
M16875-C Contact sales@xcessbio.com for quotation $100

Description

GKT136901 hydrochloride is a potent, selective and orally active inhibitor of NADPH oxidase (NOX1/4), with Kis of 160 and 165 nM, respectively. GKT136901 hydrochloride is also a selective and direct scavenger of peroxynitrite. GKT136901 hydrochloride can be used for the research of diabetic nephropathy, stroke, and neurodegeneration. GKT136901 hydrochloride also has anti-inflammatory activity.

Product information

CAS Number: 1254507-01-1

Molecular Weight: 407.29

Formula: C19H20Cl2N4O2

Chemical Name: 2-(2-chlorophenyl)-4-methyl-5-[(pyridin-2-yl)methyl]-octahydro-1H-pyrazolo[4,3-c]pyridine-3,6-dione hydrochloride

Smiles: Cl.CC1C2C(CC(=O)N1CC1=CC=CC=N1)NN(C1=CC=CC=C1Cl)C2=O

InChiKey: ZDPBRBFSARFUJA-UHFFFAOYSA-N

InChi: InChI=1S/C19H19ClN4O2.ClH/c1-12-18-15(10-17(25)23(12)11-13-6-4-5-9-21-13)22-24(19(18)26)16-8-3-2-7-14(16)20;/h2-9,12,15,18,22H,10-11H2,1H3;1H

Technical Data

Appearance: Solid Power

Purity: ≥98% (or refer to the Certificate of Analysis)

Solubility: DMSO : 62.5 mg/mL (154.99 mM; Need ultrasonic). H2O : 4 mg/mL (9.92 mM; ultrasonic and warming and heat to 60°C).

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis

Storage Condition: Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.

Shelf Life: ≥12 months if stored properly.

Stock Solution Storage: 0 - 4 oC for 1 month or refer to the Certificate of Analysis.

Drug Formulation: To be determined

HS Tariff Code: 382200

How to use

In Vitro:

GKT136901 (10 μM; 30 min) significantly attenuates high-D-glucose-induced increase in O2•− production and in H2O2 generation in MPT cells. GKT136901 (10 μM; 30 min) abolishes the effect of high D-glucose on p38MAP kinase activation in MPT cells. GKT136901 (10 μM; 2 h) attenuates methamphetamine (METH)-induced oxidative stress in HBMECs. GKT136901 (10 μM; 2 h) protects HBMECs against METH-induced blood-brain barrier (BBB) dysfunction.

In Vivo:

GKT136901 (30-90 mg/kg; daily p.o. for 16 weeks) has renoprotective effects in a mouse model of Type 2 diabetes.

Products are for research use only. Not for human use.

Payment & Security

PayPal Venmo

Your payment information is processed securely. We do not store credit card details nor have access to your credit card information.

Estimate shipping

You may also like

Recently viewed